ENDOTHELIUM-DERIVED RELAXING FACTOR ACTIVITY IN RAT LUNG DURING HYPOXIC PULMONARY VASCULAR REMODELING

被引:31
作者
ZHAO, L [1 ]
CRAWLEY, DE [1 ]
HUGHES, JMB [1 ]
EVANS, TW [1 ]
WINTER, RJD [1 ]
机构
[1] ROYAL BROMPTON HOSP,HHLI,DEPT THORAC MED,LONDON SW3 6LY,ENGLAND
关键词
PULMONARY CIRCULATION; PULMONARY ARTERY; HYPOXIA; NITRIC OXIDE; NG-MONOMETHYL-L-ARGININE; L-ARGININE;
D O I
10.1152/jappl.1993.74.3.1061
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We have investigated the role of endothelium-derived relaxing factor in modulating hypoxic pulmonary vasoconstriction by inhibiting its synthesis with the false substrate N(G)-monomethyl-L-arginine (L-NMMA) in the isolated blood-perfused lungs of Wistar rats after chronic hypoxia (CH, fractional inspiratory 0, concentration 10%) for 15 h, 2 days, and 7 days. Lungs were perfused with blood of normal hematocrit at constant flow (18 ml/min) ventilated with 1) 95% air-5% CO2 (normoxia) and 2) 2% O2-5% CO2-93% N2 (hypoxia) and were studied in the absence and presence Of L-NMMA (30 and 300 muM) or L-arginine (L-Arg, 1 and 6 mM) in separate groups. Pulmonary arterial pressure (Ppa) rose incrementally with hypoxic exposure (all P < 0.05 vs. normoxic control group). Hypoxic pulmonary vasoconstriction (HPV) was markedly reduced after 15 h and 2 days of CH: the mean increases in Ppa (DELTAPpa) in hypoxia were 15.3, 3.5, 3.8, and 13.6 mmHg in control rats and rats exposed to 15 h (P < 0.05 vs. control and 7 days of CH), 2 days (P < 0.001 vs. control and 7 days of CH), and 7 days of CH, respectively. Ppa in control rats and rats exposed to 15 h, 2 days, and 7 days of CH were 137, 179, 184, and 166% of control, respectively, after 30 muM L-NMMA (all P < 0.05 when expressed as percent change vs. no L-NMMA). Similar augmentation in HPV was seen after 30 muM L-NMMA, with all hypoxic groups having a greater response than control groups. Hypoxic Ppa in control rats and rats exposed to 15 h, 2 days, and 7 days of CH were 96, 85 (P < 0.05 vs. control), 82 (P < 0.01 vs. control), and 91% of control after 1 MM L-Arg and 88, 77 (P < 0.05 vs. control), 56 (P < 0.001 compared with control and 7 days of CH), and 82% of control after 6 MM L-Arg. The attenuation of HPV at 15 h and 2 days of CH with partial restoration toward normal by L-NMMA suggests that the early phase of CH exposure is associated with release of endothelium-derived relaxing factor.
引用
收藏
页码:1061 / 1065
页数:5
相关论文
共 35 条
[21]   BIOSYNTHESIS OF NITRIC-OXIDE FROM L-ARGININE - A PATHWAY FOR THE REGULATION OF CELL-FUNCTION AND COMMUNICATION [J].
MONCADA, S ;
PALMER, RMJ ;
HIGGS, EA .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) :1709-1715
[22]   ENDOTHELIUM-DERIVED RELAXING FACTOR - IDENTIFICATION AS NITRIC-OXIDE AND ROLE IN THE CONTROL OF VASCULAR TONE AND PLATELET-FUNCTION [J].
MONCADA, S ;
RADOMSKI, MW ;
PALMER, RMJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (13) :2495-2501
[23]  
RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH817
[24]  
RABINOVITCH M, 1979, HEART CIRC PHYSL, V5, pH817
[25]   A SPECIFIC INHIBITOR OF NITRIC-OXIDE FORMATION FROM L-ARGININE ATTENUATES ENDOTHELIUM-DEPENDENT RELAXATION [J].
REES, DD ;
PALMER, RMJ ;
HODSON, HF ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :418-424
[26]   INHIBITION OF NITRIC-OXIDE SYNTHESIS POTENTIATES HYPOXIC VASOCONSTRICTION IN ISOLATED RAT LUNGS [J].
ROBERTSON, BE ;
WARREN, JB ;
NYE, PCG .
EXPERIMENTAL PHYSIOLOGY, 1990, 75 (02) :255-257
[27]   EFFECTS OF HYPOXIA ON ENDOTHELIUM-DEPENDENT RELAXATION OF RAT PULMONARY-ARTERY [J].
RODMAN, DM ;
YAMAGUCHI, T ;
HASUNUMA, K ;
OBRIEN, RF ;
MCMURTRY, IF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (04) :L207-L214
[28]  
RODMAN DM, 1990, LUNG CELL MOL PHYSL, V2, pL207
[29]   CHANGES IN ARTERIOLE IN ACUTE AND CHRONIC HYPOXIC PULMONARY-HYPERTENSION AND RECOVERY IN RAT [J].
SOBIN, SS ;
TREMER, HM ;
HARDY, JD ;
CHIODI, HP .
JOURNAL OF APPLIED PHYSIOLOGY, 1983, 55 (05) :1445-1455
[30]   PRESSURE-INDUCED CONNECTIVE-TISSUE SYNTHESIS IN PULMONARY-ARTERY SEGMENTS IS DEPENDENT ON INTACT ENDOTHELIUM [J].
TOZZI, CA ;
POIANI, GJ ;
HARANGOZO, AM ;
BOYD, CD ;
RILEY, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) :1005-1012